Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984839 · ClinicalTrials.gov registry record
Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study
A clinical trial, sponsored by OhioHealth.
- Completed
- Registry status
- 120
- Enrollment target
NCT02984839 is a clinical trial that has completed, run by OhioHealth. The registered enrollment target is 120 participants.
The verdict
NCT02984839 has completed, sponsored by OhioHealth.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The aim of this prospective, observational study is to determine the incidence of post-operative residual neuromuscular blockade (PRNB) in patients undergoing intra-abdominal procedures compared to patients undergoing other noncardiac/non intra-thoracic procedures that also require non-depolarizing neuromuscular blocking agents (NMBA) administration. As intra-abdominal surgeries are independently associated with post-operative pulmonary complications (PPCs), it is important to highlight other factors, such as PRNB, that could contribute to these complications.Although it has been shown that the risk of adverse respiratory events can be reduced by intra-operative quantitative neuromuscular monitoring, such monitoring is not in widespread use.This study will incorporate quantitative monitoring in the post-anesthesia care unit (PACU) setting by using the Stimpod NMS450® in an effort to show a disparity in the incidence of residual paralysis between these two patient populations and to emphasize the need to implement more accurate neuromuscular monitoring, especially for those that are already at increased risk for respiratory complications.
Interventions
- DEVICE Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02984839
The ClinicalTrials.gov registry entry for NCT02984839 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology is the first listed.
NCT02984839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02984839 about?
NCT02984839 is a clinical study titled "Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observational Study". The aim of this prospective, observational study is to determine the incidence of post-operative residual neuromuscular blockade (PRNB) in patients undergoing intra-abdominal procedures compared to patients undergoing other noncardiac/non intra-thoracic procedures that also require non-depolarizing ...
What is the current status of trial NCT02984839?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2016-11. Estimated completion is 2017-05-16.
What interventions are being tested in trial NCT02984839?
The interventions under investigation include: Stimpod NMS450® Nerve Stimulator, by Xavant™ Technology (DEVICE).
Who is sponsoring clinical trial NCT02984839?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.